Vaccine supply chain bottlenecks eased, drugmakers tell Congress
Three hundred million doses from Pfizer. Three hundred million from Moderna. One hundred million from Johnson & Johnson. One hundred million from Novavax.
Three hundred million doses from Pfizer. Three hundred million from Moderna. One hundred million from Johnson & Johnson. One hundred million from Novavax.
When a large corporation puts money into a small startup, huge innovations can result — like the rapid-fire development of a COVID-19 vaccine.
The U.S. government has invested billions of dollars in manufacturing, used a wartime act dozens of times to boost supplies and yet there’s still not enough covid vaccine on the way to meet demand — or even the government’s own goals for national immunization.
The Centers for Disease Control and Prevention (CDC) order requiring international travelers coming into the U.S. to provide either proof of a negative COVID-19 test within 72 hours of traveling or proof of recovery from COVID-19 makes no sense.
The country is in a race against time to end the coronavirus pandemic. Some health experts say vaccination is the only way the U.S. will reach herd immunity. But could the country be doing better in terms of vaccine distribution?
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
An audio journey of how data and analytics save lives, save money and solve problems.
A number of startups and cloud service providers are starting to offer tools for monitoring, evaluating, and correcting problems with generative AI in the hope of eliminating errors, hallucinations, and other systemic problems associated with this technology.
Catastrophic weather events, wars in Ukraine and the Middle East, trade conflicts, global pandemics—the forces disrupting supply chains are multiplying at a rate few could have anticipated.
Tariffs could raise the cost of medical care and prescription drugs for people in the U.S.
New findings from a team of renowned researchers calls for transparency and rigorous oversight of the U.S. Medicare Advantage (MA) program, the United States' largest healthcare capitation program.
LONDON, Dec 30 (Reuters) - Chemicals factories founded or owned by some of Russia's wealthiest men are supplying ingredients to plants that manufacture explosives used by Moscow's military during the war in Ukraine, an analysis of railway and financial data shows.
During the holiday season, a late delivery can sometimes feel like the end of the world. You’ve been there: you order a highly anticipated gadget, new clothes, or a last-minute gift, only to find out that your delivery is delayed. While many blame shipping companies or delivery drivers, the true culprit often lies deeper in the supply chain — at the heart of it all: forecasting.
Billionaire investor Mark Cuban's question to Representative Matt Gaetz, a Florida Republican, on energy costs took off on social media on Saturday.
Florida lawmakers have banned wind turbines off its shores and near the coast, saying the bill is meant to protect wildlife and prevent noise.